European CDMO partner and API manufacturer since 1951
High-potent APIs (OEB 6), payload-linkers for ADC, oligonucleotides, cryogenic, synthetic chemistry and particle engineering. Supporting pharma and biotech from early development to commercial GMP supply
.webp)
Discover the Cutting-Edge Technologies
Behind Polpharma API's
CDMO
We develop and manufacture small-molecule and complex APIs, HP APIs, payloads and linkers for ADC and oligonucleotides for pharmaceutical and biotechnology partners, handling everything from early clinical batches to full commercial supply from a single, integrated European site.
Generics
We manufacture our products by following our customers’ and health authorities’ most stringent requirements. DMF documentation for all our products is prepared in accordance with the latest requirements. Our product portfolio covers 8 therapeutic categories, including oncology, diabetology & cardiology.
Technologies
High-potency/oncology APIs with containment to OEL 10 ng/m³ (OEB 6); payload–linkers for ADC; oligonucleotides; cryogenic chemistry down to −90°C; broad synthetic chemistry; particle engineering and polymorph control; full analytical development and stability.
Polpharma API
We partner with biotech and pharmaceutical companies developing demanding molecules — high-potency and oncology compounds, ADC payload–linkers, and oligonucleotides — that seek an FDA-approved European partner with high-containment expertise and a proven regulatory track record to carry projects from early clinical batches to commercial scale.
